FOGNANI, ELISA
 Distribuzione geografica
Continente #
NA - Nord America 3.469
EU - Europa 2.441
AS - Asia 1.162
SA - Sud America 169
AF - Africa 29
OC - Oceania 21
Continente sconosciuto - Info sul continente non disponibili 1
Totale 7.292
Nazione #
US - Stati Uniti d'America 3.412
PL - Polonia 728
RU - Federazione Russa 689
IT - Italia 398
SG - Singapore 331
CN - Cina 249
HK - Hong Kong 189
IE - Irlanda 167
VN - Vietnam 163
BR - Brasile 133
SE - Svezia 131
FI - Finlandia 80
KR - Corea 79
DE - Germania 74
FR - Francia 53
GB - Regno Unito 39
IN - India 37
CA - Canada 36
JP - Giappone 25
ES - Italia 22
AU - Australia 21
ID - Indonesia 20
AR - Argentina 17
JO - Giordania 15
TR - Turchia 14
BE - Belgio 13
MX - Messico 12
NL - Olanda 10
ZA - Sudafrica 10
IQ - Iraq 9
BD - Bangladesh 7
CI - Costa d'Avorio 7
UA - Ucraina 7
EC - Ecuador 6
PH - Filippine 6
CO - Colombia 4
MA - Marocco 4
RO - Romania 4
DK - Danimarca 3
HN - Honduras 3
HU - Ungheria 3
NG - Nigeria 3
UZ - Uzbekistan 3
VE - Venezuela 3
CH - Svizzera 2
CR - Costa Rica 2
CZ - Repubblica Ceca 2
EG - Egitto 2
GR - Grecia 2
LT - Lituania 2
MD - Moldavia 2
MT - Malta 2
NP - Nepal 2
PY - Paraguay 2
SK - Slovacchia (Repubblica Slovacca) 2
TH - Thailandia 2
UY - Uruguay 2
AZ - Azerbaigian 1
BH - Bahrain 1
BM - Bermuda 1
BY - Bielorussia 1
CL - Cile 1
EU - Europa 1
IL - Israele 1
JM - Giamaica 1
KE - Kenya 1
KH - Cambogia 1
KW - Kuwait 1
KZ - Kazakistan 1
LV - Lettonia 1
MY - Malesia 1
NO - Norvegia 1
PE - Perù 1
PK - Pakistan 1
PR - Porto Rico 1
PT - Portogallo 1
RS - Serbia 1
SA - Arabia Saudita 1
SI - Slovenia 1
SN - Senegal 1
SV - El Salvador 1
SY - Repubblica araba siriana 1
TN - Tunisia 1
TW - Taiwan 1
Totale 7.292
Città #
Santa Clara 805
Warsaw 725
Ashburn 398
Fairfield 279
Singapore 215
Dublin 167
Hong Kong 154
San Jose 148
Woodbridge 144
Chandler 143
Cambridge 123
Seattle 121
Houston 114
Beijing 110
Wilmington 109
Ann Arbor 81
Milan 78
Seoul 76
The Dalles 67
Altamura 56
Florence 56
Lawrence 49
Ho Chi Minh City 48
Buffalo 47
Princeton 46
Lauterbourg 38
Helsinki 36
Bremen 33
Hanoi 32
Mumbai 29
Council Bluffs 28
Los Angeles 26
Munich 25
Rome 25
Boston 24
Medford 23
New York 23
Tokyo 22
Shanghai 21
Dong Ket 20
Falls Church 20
Boardman 19
Melbourne 19
Jakarta 14
San Diego 14
Brussels 13
Dallas 13
Barcelona 11
Cagliari 11
Clifton 11
London 11
São Paulo 11
Montreal 10
Norwalk 10
Izmir 9
Moscow 9
Turku 9
Naples 8
Abidjan 7
Frankfurt am Main 7
Jacksonville 7
Old Bridge 7
Phoenix 7
Atlanta 6
Bologna 6
Johannesburg 6
Redondo Beach 6
Turin 6
Brooklyn 5
Mexico City 5
Miano 5
Modena 5
Vancouver 5
Verona 5
Washington 5
Avigliano 4
Bari 4
Chicago 4
Cluj-Napoca 4
Curitiba 4
Da Nang 4
Figino 4
Istanbul 4
Madrid 4
Orem 4
Paris 4
Portsmouth 4
Toronto 4
Abuja 3
Andover 3
Birmingham 3
Biên Hòa 3
Brasília 3
Chennai 3
Ferriere 3
Forlì 3
Fortaleza 3
Guangzhou 3
Guayaquil 3
Haiphong 3
Totale 5.174
Nome #
Hepatitis C Virus infection in the immunocompromised host: a complex scenario with variable clinical impact 334
Role of MicroRNA Profile Modifications in Hepatitis C Virus-Related Mixed Cryoglobulinemia 319
Notch4 and mhc class II polymorphisms are associated with hcv-related benign and malignant lymphoproliferative diseases 269
Determinanti virali e dell’ospite nella patogenesi dei disordini linfoproliferativi HCV-correlati 265
Impact of immunogenetic IL28B polymorphism on natural outcome of HCV infection. 264
Efficacy of low-dose rituximab for the treatment of mixed cryoglobulinemia vasculitis: Phase II clinical trial and systematic review 257
A serum metabolomic analysis of HCV-infected patients successfully treated with IFN-free DAA regimens 253
A phase II, single-arm multicenter study of low-dose rituximab for refractory mixed cryoglobulinemia secondary to hepatitis C virus infection 249
Autoimmunity and lymphoproliferation markers in naïve HCV-RNA positive patients without clinical evidences of autoimmune/lymphoproliferative disorders 234
Prospective study of guideline-tailored therapy with direct-acting antivirals for hepatitis C virus-associated mixed cryoglobulinemia 234
HCV-related liver and lymphoproliferative diseases: Association with polymorphisms of IL28B and TLR2 233
Combined treatment with antiviral therapy and rituximab in patients with mixed cryoglobulinemia: review of the literature and report of a case using direct antiviral agents-based antihepatitis C virus therapy 230
Deregulation of microRNA expression in peripheral blood mononuclear cells from patients with HCV-related malignancies 228
Host genetic determinants in HCV-related mixed cryoglobulinemia 205
IgG3 subclass: A possible trigger of mixed cryoglobulin cascade in hepatitis C virus chronic infection 205
Long-term effect of HCV eradication in patients with mixed cryoglobulinemia: A prospective, controlled, open-label, cohort study. 204
Host genetic determinants in HCV-related mixed cryoglobulinemia 198
MicroRNA expression in hepatitis C virus-related malignancies: A brief review 193
Hepatitis C virus-related mixed cryoglobulinemia: is genetics to blame? 186
Triple antiviral therapy in hepatitis C virus infection with or without mixed cryoglobulinaemia: A prospective, controlled pilot study. 179
microRNA PROFILE MODIFICATIONS IN HEPATITIS C VIRUS-RELATED MIXED CRYOGLOBULINEMIA 173
ETIOLOGICAL THERAPY IN HCV-RELATED MIXED CRYOGLOBULINEMIA SYNDROME: THE ROLE OF IL28B GENOTYPE AS PREDICTOR OF RESPONSE 171
Host genetic determinants in HCV-related mixed cryoglobulinemia 169
Genetic determinants in Hepatitis C Virus-associated mixed cryoglobulinemia: role of polymorphic variants of BAFF promoter and Fc-gamma receptors 158
Could the presence of Mixed Cryoglobulinemia influence the outcome of standard peg-IFN plus ribavirin anti-HCV therapy? 157
HCV-related lymphatic and hepatic malignancies are associated with different microRNA expression patterns in PBMCs 151
The role of the rs12979860 polymorphism of the interleukin-28b as predictor of spontaneus clearance of HCV infection in patients with hemophilia 150
Response to IFN-based antiviral therapy and long term effect of HCV eradication in Mixed Cryoglobulinemia, with or without symptoms: a prospective, controlled, open-label, long term, cohort study 148
Interferon lambda 3 rs12979860 polymorphism in patients with haemophilia and HCV infection: a predictor of spontaneous viral clearance and sustained virological response. 139
VALUE OF IL28B GENOTYPING IN PATIENTS WITH HCV-RELATED MIXED CRYOGLOBULINEMIA: RESULTS OF A LARGE, PROSPECTIVE STUDY 137
HCV AND lymphoma: Genetic and epigenetic factors 137
Il polimorfismo dell'interleuchina 28B come predittore di risposta in pazienti con crioglobulinemia mista HCV-correlata 135
IL28B POLYMORPHISM AS PREDICTOR OF RESPONSE TO ANTI-HCV THERAPY IN HCV-RELATED MIXED CRYOGLOBULINEMIA SYNDROME 133
Sofosbuvir/Ribavirin in GT2 HCV-Related symptomatic mixed cryoglobulinemia: an interim analysis on safety, efficacy and impact on quality of life 126
Mixed cryoglobulinemia syndrome is a negative prognostic factor in the standard of care (Peg-IFN+ribavirin) anti-HCV therapy 125
Long-term outcome of HCV-related mixed cryoglobulinemia in patients achieving sustained viral sustained viral response (SVR) after antiviral therapy 122
Hepatitis C-associated B-cell non-Hodgkin lymphomas: The emerging role of miRNA-26 121
IL28B polymorphism as predictor of response to anti-HCV terapy in HCV-related mixed cryoglobulinemia syndrome 120
Totale 7.311
Categoria #
all - tutte 18.555
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 18.555


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/2022316 4 26 21 16 17 23 7 22 17 17 50 96
2022/2023768 69 120 43 65 60 137 98 47 86 2 26 15
2023/2024214 10 36 41 9 9 30 3 54 4 4 5 9
2024/20251.991 85 187 124 279 641 311 14 112 91 38 63 46
2025/20261.981 238 233 96 171 197 93 222 92 212 132 37 258
2026/202751 51 0 0 0 0 0 0 0 0 0 0 0
Totale 7.311